AtaiBeckley Inc. (ATAI) analyst actions
Rating and price-target actions on ATAI in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ATAI overview →
2 measured ATAI analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation | Press release | -0.28% | +0.83% | |
| BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day | Press release | +0.26% | +7.81% |
Keep exploring
More ATAI: earnings → · SEC filings → · ATAI overview →
Other Consumer Defensive names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Central Garden & Pet Company (CENT) | 311 | +0.12% | 57% |
| Flowers Foods, Inc. (FLO) | 309 | -0.09% | 44% |
| Boston Beer Company, Inc. (The) (SAM) | 303 | +0.05% | 52% |
| SpartanNash Company (SPTN) | 301 | -0.08% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.